Frontlight ResearchEarly access
Trial site
Ajou University Hospital
- 7running trials
- 7closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Gastric and oesophageal cancer2 trials
- Chronic kidney disease1 trial
- Chronic spontaneous urticaria1 trial
- IgA nephropathy1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 25 trials
- Phase 35 trials
- Phase 1/22 trials
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novo Nordisk A/S2 trials
- Asan Medical Center1 trial
- BeiGene1 trial
- Coherus Oncology, Inc.1 trial
- Curacle Co., Ltd.1 trial
- and 8 more
Running trials
Not yet recruiting
Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic spontaneous urticaria1 recruiting
- Lung cancer1 recruiting
- Obesity1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Terminated
Completed
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026